Orphenadrine and Methocarbamol for LBP
| Status: | Completed |
|---|---|
| Conditions: | Back Pain, Back Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 69 |
| Updated: | 6/28/2018 |
| Start Date: | March 2016 |
| End Date: | May 2017 |
Methocarbamol and Orphenadrine for Acute, Non-traumatic, Non-radicular Low Back Pain: A Randomized, Placebo Controlled, 3-armed Study
Low back pain is a common cause of visit to emergency department. It is not clear if skeletal
muscle relaxants are of benefit for patients with acute low back pain. This is a randomized
study to determine if skeletal muscle relaxants, when combined with naproxen, improve
outcomes more than naproxen alone
muscle relaxants are of benefit for patients with acute low back pain. This is a randomized
study to determine if skeletal muscle relaxants, when combined with naproxen, improve
outcomes more than naproxen alone
Patients with acute, non-traumatic, non-radicular low back pain will be enrolled at the time
of discharge from the emergency department. Participants will be followed by telephone one
week and 3 months after the ED visit
of discharge from the emergency department. Participants will be followed by telephone one
week and 3 months after the ED visit
Inclusion Criteria:
- LBP duration <= 2 weeks
- No trauma to low back within previous month
- No radicular symptoms
- No history of low back pain or history of only infrequent episodes
Exclusion Criteria:
- Medication allergies or contra-indications
- Not available for follow-up
- Chronic pain syndrome
We found this trial at
1
site
3550 Jerome Avenue
Bronx, New York 10467
Bronx, New York 10467
(718) 920-4321
Principal Investigator: Benjamin W Friedman, MD, MS
Phone: 718-920-6626
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
